Advertisement

Bharat Biotech seeks nod for intranasal Covid-19 vaccine as booster Dose

Bharat Biotech seeks approval for Phase 3 clinical trials of its intranasal vaccine, a first of its kind in India. It has recommended nasal vaccine for booster dose. Bharat Biotech is the second company to submit an application for Phase 3 trial for the third dose in India.

Read More

VIDEOS FROM OTHER SECTIONS

LATEST VIDEOS

Congress to support TVK in Tamil Nadu, demands 2 cabinet berths: Sources

The Congress state unit in Tamil Nadu held an online meeting and decided to extend support to TVK. Congress is seeking a power-sharing agreement and is likely to demand two cabinet portfolios, along with a few board and corporation chairman posts, and other government roles such as trust members and directors.

advertisement